The Effect of Hologram Application on Pain, Anxiety, and Fear Levels in Children During Burn Dressing
NCT06992895
Summary
The process of dressing burn injuries has been shown to cause both physical and psychological difficulties. In children, this process is particularly associated with intense pain and anxiety. Consequently, in addition to pharmacological interventions, non-pharmacological methods such as distraction are employed. In recent years, the utilization of holograms as a method of alleviating pain has emerged as a novel approach. The employment of these visual illusions has been demonstrated to effectively distract children, thereby providing a means of reducing discomfort. The objective of this thesis is to evaluate the effects of hologram application on pain, anxiety, fear, and vital signs during burn dressing in children.
Eligibility
Inclusion Criteria: * The subject has indicated their willingness to participate in the study. Physical and mental health. * The age range of the subjects included in this study was from 3 to 12 years of age. * The subject had never previously engaged in the practice of dressing a burn. * The presence of only second degree burns * Burn percentage is under 10% Exclusion Criteria: * The subject is unwilling or unable to provide informed consent or assent (if applicable). * The subject has a history of significant physical or mental health disorders that may interfere with participation in the study. * The subject is younger than 3 years old or older than 12 years old. * The subject has previously engaged in the practice of burn dressing or similar procedures. * The presence of burns other than second-degree burns (e.g., first-degree or third-degree burns). * The percentage of burn area is greater than 10%.
Conditions3
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06992895